New antibiotic uses novel method to target deadly drug-resistant bacteria, study says

Scientists say they have developed a new type of antibiotic to treat bacteria that is resistant to most current antibiotics and kills a large percentage of people with an invasive infection.

Zosurabalpin defeated highly drug-resistant strains of Carbapenem-resistant Acinetobacter baumannii (Crab) in mouse models of pneumonia and sepsis, and was being tested in human trials.

Zosurabalpin is in now in phase 1 clinical trials to assess the safety, tolerability and pharmacology of the molecule in humans, according to scientists.